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INTRODUCTION
Recent studies suggest the role of hypoxia in the tubuloin-
terstitium as a common final pathway to end-stage renal dis-
ease (1-3). Hypoxia has been shown to induce cellular prolif-
eration and extracellular matrix (ECM) synthesis by cultured
mesangial cells (4, 5) and fibroblasts (6). Hypoxia has also
been shown to increase ECM synthesis in renal tubular epithe-
lial cells as well as inducing epithelial-to-mesenchymal trans-
differentiation (EMT) and apoptosis (1, 7). Chronic renal hy-
poxia may occur by changes of oxygen supply (hypoxic injury)
or impairment of blood flow to tubulointerstitium. Histo-
logic studies of animal model and human kidney suggest that
insufficient oxygenation resulting from peritubular capillary
loss has a pivotal role in the pathogenesis of renal disease (8,
9). But, the underlying signaling mechanisms whereby hypox-
ia alters cellular behaviors remain poorly defined. Hypoxia can
regulate expressions of a variety of growth factors and cytokines
in a cell and tissue-specific manner. These include transform-
ing growth factor-β(TGF-β ), vascular endothelial growth
factor (VEGF), and endothelin-1 (ET-1) (10).
Connective tissue growth factor (CTGF) is a 38 kD cysteine-
rich heparin-binding protein belonging to the CCN family
and involves in stimulation of proliferation, angiogenesis, mi-
gration, ECM production, cell attachment, cell survival and
apoptosis (11). TGF-βenhances CTGF mRNA and protein
expression in mesangial cells (12). CTGF has been proposed
to play an important role in tubulointerstitial fibrosis as one
of the major mediators of TGF-β . It has been shown to be
hypoxia-inducible in human breast cancer cells (13). Higgins
et al. were the first to show hypoxic induction of CTGF in
renal tubular epithelial cell cultures (14). But, the precise sig-
naling mechanisms of the hypoxia-induced expression of CTGF
remain unclear.
In the present study, we investigated: 1) the effect of hypoxia
on TGF-βconcentration in conditioned medium and CTGF
gene expression in cultured renal tubular cells; 2) what kind
of mitogen-activated protein (MAP) kinase is involved in
hypoxia-stimulated CTGF mRNA expression; and 3) whether
hypoxia-induced CTGF mRNA expression is mediated by
the release of TGF-β 1.
MATERIALS AND METHODS
Cell culture and hypoxic condition
Mouse tubular cells (MTC) are a proximal epithelial cell
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Hypoxia Induces Connective Tissue Growth Factor mRNA Expression
Connective tissue growth factor (CTGF) is known to be a profibrotic growth factor,
which mediate the fibrotic effect of transforming growth factor-β(TGF-β ) and to stim-
ulate cell proliferation and matrix production. CTGF has been shown to be hypoxia-
inducible in several cell types. Here we investigated the effect of hypoxia on CTGF
gene expression in cultured mouse renal tubular cells (MTC). Quiescent cultures of
MTC were exposed to hypoxia (1% O2) or normoxia in serum-free medium. The
effects on hypoxia-induced CTGF expression were evaluated by Northern blot and
real-time PCR. The roles of mitogen-activated protein kinase (MAPK) and TGF-β
were also determined using specific biochemical inhibitors. Exposure of quiescent
tubular cells to hypoxia for 24 hr in a conditioned medium resulted in a significant
increase TGF-β . Hypoxia caused a significant increase in CTGF mRNA expression
in MTC. Either JNK or ERK inhibitor did not block the hypoxia-induced stimulation of
CTGF, whereas an inhibitor of p38 MAPK reduced the hypoxia-induced changes of
CTGF. Although hypoxia stimulated TGF-βproduction, neutralizing anti-TGF-β 1
antibody did not abolish the hypoxia-induced CTGF mRNA expression. The data
suggest that hypoxia up-regulates CTGF gene expression, and that p38 MAPK plays
a role in hypoxic-stimulation of CTGF. We also demonstrated that hypoxia induces
CTGF mRNA expression via a TGF-β 1-independent mechanism.
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line isolated from 8-10-week-old naive SJL/J (H-2
s) mice as
previously described (15) and cultured in renal epithelial cell
basal medium (REBM) (Clonetics, San Diego, CA, U.S.A.)
containing 5% fetal bovine serum (FBS), 5,000 U/mL peni-
cillin, 5,000 μ g/mL streptomycin, and L-glutamine. Cultures
were maintained in 75 cm
3flasks at 37℃under a humidified
atmosphere of 5% CO2/95% air. Cells were passed by tripsi-
nization after they reached 80% confluency and utilized be-
tween passages three and seven for all of the studies. Conflu-
ent cells were made quiescent by 24 hr incubation in serum-
free medium.
Fresh quiescence medium was added and cells were exposed
to 1% O2, 4% CO2, 95% N2 in an Anaerobic system 1,029
(Forma Scientific, Marietta, OH, U.S.A.) in open dishes. Cells
were overlaid with medium to a depth of 3 mm sufficient to
prevent dehydration. Control dishes were incubated for equiv-
alent periods under normoxic conditions (21% O2, 5% CO2,
37℃). The tetrazolium dye-reduction assay (MTT; 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide;
Sigma) was used to test cell viability before and at end of treat-
ment and did not reveal any signs of increased cell death in
hypoxia (data not shown).
RNA extraction and Northern blot analysis
To determine the effect of hypoxia on CTGF gene expres-
sion, MTC were grown in hypoxic condition for up to 10 hr.
At the end of each incubation time, cultures were harvested
and total cellular RNA was extracted using TRIZOLRReagent
(Gibco-BRL, MD, U.S.A.) according to the manufacturer’s
instructions. Thirty micrograms of total RNA were electro-
phoresed on a 1.2% formaldehyde-agarose gel and ethidium-
bromide-stained gels were photographed under UV illumi-
nation. RNA was transferred to nitrocellulose membranes
for 3 hr. Membranes were prehybridized for 1 hr at 68℃ in
Quick Hyb Buffer (Stratagene, La Jolla, CA, U.S.A.) and
hybridized for 3 hr in the same solution containing the 32P-
labeled cDNA probes for human CTGF at 68℃. The blots
were then washed two times, 30 min each in 4×SSC, 0.1%
SDS at 68℃ followed by three 1 hr washes with 0.2×SSC,
0.1% SDS at 55℃. The blots were exposed to Kodak XAR-
5 film (Eastman Kodak, Rochester, NY, U.S.A.). Photographs
of ethidium bromide-stained gels and autoradiograms were
scanned and quantified by densitometry. To control for rela-
tive equivalence of RNA loading, the blots were hybridized
with β -actin cDNA (Clothech) probe or an oligonucleotide
probe corresponding to the 18S rRNA. Data are expressed
as relative mRNA levels calculated as a relative ratio of con-
trol value from arbitrary densitometry units.
Real-time PCR
CTGF mRNA transcripts were detected by a real-time
quantitative real-time PCR procedure using ABI Prism 7000
Sequence Detection System (PE Applied Biosystems, Foster
City, CA, U.S.A.). This system is based on the ability of the
5′ nuclease activity of Taq polymerase to cleave a dual-labeled
fluorogenic hybridization probe during DNA chain exten-
sion. The probe is labeled with a reporter fluorescent dye
FAM at the 5′ end and a quencher fluorescent dye TAMRA
(6-carboxy-tetramethyl-rhodamine) at the 3′ end. During
the extension phase of PCR, the nucleolytic activity of the
DNA polymerase cleaves the hybridization probe and releases
the reporter dye from the probe with concomitant increase in
reporter fluorescence. The following sequence-specific primers
and probes were designed using Primer Express software (PE
Applied Biosystems, Foster City, CA, U.S.A.): Rat CTGF
forward primer: 5′ -CAA GCT GCC CGG GAA AT-3′ ,
reverse primer: 5′ -CGG TCC TTG GGC TCA TCA-3′ , and
probe: 5′ FAM-CTG TGA GGA GTG GGT-MGBNFQ-
3′ ; 18S rRNA forward primer 5′ -CGG CTA CCA CAT
CCA AGG AA-3′ , reverse primer: 5′ -GCT GGA ATT ACC
GCG GCT-3′ : probe 5′ VIC-TGC TGG CAC CAG ACT
TGC CCT C-TAMRA 3′ . Primers were used at a concentra-
tion of 900 nM and probes at 100 nM at each reaction. Reac-
tions were assembled in a 96-well optical reaction plate. Each
reaction contained 1×master mix from the kit (TaqMan One-
Step RT-PCR Master Mix; Applied Biosystems, Inc.), forward
primer, reverse primer, fluorescent probe, and RNA sample
to a final volume of 25 μ L per reaction. The plate was analyzed
on a sequence-detection system, which simultaneously per-
forms RT-PCR and detects fluorescence signal. 
TGF-β β 1 ELISA
The cell supernatant was collected at each time point, clar-
ified by centrifugation at 1,500×g for 5 min at 4℃and stored
at -80℃. Release of TGF-β 1 into culture supernatant of cells
was measured using corresponding ELISA kits according to
the manufacturer’s instructions (R&D Systems, Minneapolis,
MN, U.S.A.). As the ELISA only measured levels of the active
protein, activation of the supernatant was performed to mea-
sure the total levels of both proteins. Briefly, cell supernatants
were activated with 1.0 N HCl and subsequently neutralized
with 1.2 N NaOH/0.5 M HEPES. Acid-activated samples
were added to the precoated microplates and incubated at room
temperature for 2 hr. A second antibody, anti-TGF-β 1 poly-
clonal antibody, was then added followed by TGF-β 1 horseradish
peroxidase conjugate. TGF-β 1 was detected by adding the
chromogenic substrate and this was followed by stop solution.
Absorbance was determined at optical density 450 nm.
Effect of MAP kinase inhibitors on CTGF gene
expression
We also examined the role of MAP kinase in stimulation
of CTGF mRNA induced by hypoxia. Cells were pretreated
with MAP kinase inhibitors for 30 min, and incubated under
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hypoxic or normoxic conditions for 4 hr. Inhibitors were: PD-
098059, SB-203580 and JNK inhibitor (all from Calbiochem,
La Jolla, CA, U.S.A.). At the end of incubation, the hypox-
ia-induced CTGF expression was evaluated by Northern blot
and RT-PCR. 
Neutralization TGF-β β 1 activity
To determine whether the effects of hypoxia on CTGF gene
expression are mediated by TGF-β 1, anti-TGF-β 1 antibody
(2 μ g/mL; R&D Systems, Minneapolis, MN, U.S.A.) was added
to cells for 30 min immediately before hypoxia. Parallel exper-
iments were undertaken without anti-TGF-β 1 antibody. Lev-
els of CTGF mRNA expression were measured by RT-PCR
as described above.
Statistical analysis
Results are expressed as mean±SD of the mean. Statisti-
cal significance (p<0.05) was evaluated using Student’s t-test
or one-way analysis of variance. All experiments were repeat-
ed at least three times with reproducible results.
RESULTS
Effect of hypoxia on CTGF mRNA expression
We then examined the effect of hypoxia on CTGF gene
expression in MTC. Quiescent cultures were exposed in serum-
free medium to hypoxia for 2, 3, 4, 6, 8, or 10 hr. At the end
of each incubation time, CTGF gene expression was assessed
by Northern blot analysis. As shown in Fig. 1, hypoxia caused
a significant increase in CTGF mRNA expression in MTC.
The steady-state level of CTGF mRNA was maximally up
regulated by 3-fold within 4 hr as compared with the cells
cultured under the normoxic condition. Subsequently, there
was a decline, but a 2-fold elevated level was maintained for
10 hr.
Role of MAP kinase in hypoxia-induced stimulation of
CTGF mRNA
Since TGF-βhas been reported to activate the MAP kinase
pathway (16-18), we tested the possible participation of MAP
kinases in hypoxia-induced CTGF expression. We examined
the activation of MAP kinase in response to hypoxia over 4-hr
period. To inhibit MAP kinase, ERK inhibitors (PD-098059,
50 μ M/L), p38 inhibitor (SB-203580, 20 μ M/L) or JNK
inhibitor (20 μ M/L) was incubated 30 min before hypoxic
stimulation. The effects of MAP kinase on hypoxia-induced
CTGF gene expression were studied by RT-PCR (Fig. 2). Inter-
estingly, ERK, p38 and JNK showed a different response to
hypoxia on CTGF mRNA expression. Either JNK or ERK
inhibitor did not block the up-regulation by hypoxia of CTGF
Fig. 1. Time course of CTGF mRNA expression in response to hypox-
ia. MTC were isolated, cultured until 80% confluent, and exposed
to 1% oxygen for 0-10 hr. CTGF transcripts were detected by North-
ern blot analysis; a representative blot is shown along with ethidi-
um bromide stained 28S and 18S rRNA for loading. Densitomet-
ric analysis for CTGF mRNA levels is shown normalized to 18S rRNA
level. Data are representative of three separate experiments. 
*p<0.05 compared with 0 hr sample.
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Fig. 2. Effects of MAPK inhibitors on hypoxia-induced CTGF expres-
sion. Quiescent cells were pretreated for 30 min either with PD-
098059 (PD, 50 μ M/L), SB-203580 (SB, 20 μ M/L), or JNK inhibitor
(20 μ M/L) followed by exposure to hypoxia or normoxia for 4 hr.
At the end of incubations, total RNA was prepared from the cells
and subjected to and RT-PCR. *p<0.05 compared with hypoxia. 
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expression, whereas an inhibitor of p38 MAP kinase reduced
the hypoxia-induced stimulation of CTGF. 
TGF-β β stimulation of CTGF expression
TGF-βhas been shown to increase the expression of CTGF
by a variety of cells (12, 19, 20). As a foundation for defining
the TGF-β 1 regulating CTGF expression in our system, we
first determined the response of cultured renal tubular cells to
TGF-β 1. Quiescent cultures of MTC were exposed to normox-
ic condition in serum-free medium, and then treated with
10 ng/mL TGF-β 1 for 8 hr. A time-course study of the response
demonstrated that there was a little delay before the level of
CTGF mRNA began to increase after the addition of TGF-β 1
(Fig. 3). TGF-β 1 induced the expression of CTGF mRNA
that began within 30 min, peaked at 2 hr and then declined
by 8 hr. 
Time-dependent effect of hypoxia on TGF-β β synthesis
TGF-β 1 is the major fibrogenic cytokine within the kid-
ney and induced by hypoxia in a variety of cell types. Con-
centrations of TGF-β 1 by MTC was examined using ELISA
to measure TGF-β 1 in the cell supernatant (Fig. 4). Hypox-
ia induced a 91% increase in the amount of TGF-β 1 after 4
hr of hypoxia: 30.14±13.30 ng/mL vs. 15.74±2.92 ng/mL
in control. Assay of the cell supernatant in the 24-hr hypoxia
showed a 161% increase in the amount of TGF-β 1 (41.16±
6.31 ng/mL).
Effect of anti-TGF-β β 1 antibody on hypoxia-induced
CTGF gene expression
Since CTGF is an response gene to TGF-βstimulation, we
tested whether TGF-βsynthesis was required for the enhanced
expression of CTGF by hypoxia, MTC were exposed to hypox-
ia for 4 or 8 hr in the presence of anti-TGF-β 1 antibody (2 μ g/
mL) to block TGF-βproduced by the cells after hypoxia. The
results showed that hypoxia produced substantial increases in
Fig. 3. TGF-β 1 stimulation of CTGF in normoxic condition. TGF-β 1
induces CTGF mRNA in cultured MTC. Tubular cells were serum
starved for 24 hr before being treated with 10 ng/mL TGF-β 1. Cells
were harvested at various time points and RNA was extracted. No-
rthern hybridization for CTGF mRNA levels were performed and
normalized against endogenous 18S ribosomal RNA. *p<0.05 com-
pared with 0 hr sample.
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Fig. 5. Effects of anti-TGF-β 1 antibody on CTGF activity exposed
to hypoxia. MTC were exposed to hypoxia in the presence of 2 μ g/
mL of anti-TGF-β 1 antibody for 30 min, followed by exposure to hy-
poxia for 0-8 hr. Relative CTGF levels were calculated as a percent-
age of the relevant control values from arbitrary densitometry units.
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the level of CTGF mRNA in both the absence and the pres-
ence of anti-TGF-β 1 antibody (Fig. 5). These findings suggest-
ed that TGF-β 1 synthesis was not required for hypoxia-induced
stimulation of CTGF and TGF-β 1 is not the primary medi-
ator of the hypoxia-induced CTGF gene expression.
DISCUSSION
In this study, we found that hypoxia stimulated TGF-β 1
and CTGF expression in cultured renal tubular cells. We also
demonstrated that either JNK or ERK inhibitor did not block
hypoxia-mediated CTGF expression, whereas an inhibitor of
p38 MAP kinase reduced the expression of CTGF. Although
hypoxia stimulated TGF-βproduction, neutralizing anti-
TGF-β 1 antibody did not abolish the hypoxia-induced CTGF
mRNA expression. These data suggest that hypoxia regulates
CTGF expression through TGF-β 1-independent mechanism.
A number of studies have shown that hypoxia leads to pro-
fibrotic responses in tubular epithelial cells and renal fibrob-
lasts (2, 5, 6). Since tubular hypoxia is present in the early
stage of disease in a progressive glomerulonephritis model
(8), hypoxia from peritubular capillary loss may contribute
to the process of renal fibrosis. Although numerous signal-
ing pathways have been implicated in hypoxic signal trans-
duction, the specific mechanisms underlying the fibrogenic
response to hypoxia remain unknown. These could be medi-
ated by direct effects on gene expression via hypoxia response
elements (HRE) present in the gene promoters or secondary
factors induced by hypoxia (14, 21). At the center of this cel-
lular response to hypoxia is hypoxia-inducible factor (HIF)
(22, 23). HIF is composed of two subunits, an oxygen-sensitive
HIF-a subunit and a constitutively expressed HIF-b subunit
(1). Hypoxia also modulates the activation of Nuclear factor-
kappaB (NF-κ B) in cells through decreased oxygen-depen-
dent suppression of the key regulators of this pathway (24).
Hypoxia has been reported to stimulate the production of a
variety of growth factors including the profibrotic factor,
TGF-β , in multiple cell types (10, 25, 26). In our study, hypoxic
treatment produced a 2- to 3-fold increase in the level of
TGF-β 1 in the cell supernatant. The period of hypoxia in this
study (24 hr, 1% O2) was based on data showing that in vitro
exposure of various cell lines to 1% O2 for a minimum of 16
hr alters gene expression (25). Although previous studies
showed that 24 hr of hypoxia induced a increase in the level
of TGF-β 1 (27), we have shown the shorter period of hypox-
ia also increased TGF-β 1 production. 
CTGF has recently received much attention as a key deter-
minant of progressive fibrosis and also wound repair, neoan-
giogenesis, bone formation and embryonic development (28).
Comparison of the mouse and rat CTGF proteins showed a
95% identity and the rat CTGF protein also showed 91%
identity to the human CTGF protein (29). TGF-βinduces
CTGF through different signaling pathways and a specific
TGF-βresponsive element in the CTGF promotor (12). CTGF
is thought to act both as a profibrotic marker and as a down-
stream mediator of TGF-β . In the present cell culture system,
TGF-β 1 produced a 15-fold increase in the level of CTGF
mRNA. The induction of CTGF mRNA by TGF-β 1 was also
found in renal fibroblasts (unpublished observations). These
results are consistent with observations in other cell systems
where TGF-βinduces CTGF expression (12, 19, 20). It has
previously been found that CTGF was regulated by hypoxia
in a human breast cancer cell line, MDA231 (13). Our pre-
sent study demonstrated that hypoxic treatment lead to sig-
nificant elevation of CTGF mRNA in renal tubular cells. But,
we have not measured CTGF protein levels. The steady-state
level of CTGF mRNA in MTC was maximally up-regulated
by 3-fold within 4 hr as compared with that from the normox-
ic condition. Subsequently, there was a decline, but a 2-fold
elevated level was maintained for 10 hr. Similarly, hypoxia
(0.5% O2) has been shown to stimulate CTGF mRNA by
2-fold in renal tubular epithelial cells (14).
Since transcription is the major level of modulation of CTGF
expression by TGF-β 1 and since TGF-βhas been reported to
activate the MAP kinase pathway (16-18), we tested what
kind of kinase was involved in hypoxia-induced CTGF expres-
sion. We found distinct difference in the role of MAP kinas-
es in mediating CTGF expression in response to hypoxia. An
inhibitor of p38 MAP kinase (SB-203580) reduced hypoxia-
stimulated CTGF expression, whereas either JNK or ERK
inhibitor (PD-098059) did not block the expression of CTGF.
The roles of MAP kinases under hypoxia are complicated,
which depend on the specific cell types. ERK activation has
been shown to be critical in hypoxia-induced VEGF expres-
sion in HepG2 cells (30). In contrast, the study using NRK52
cells, ERK activation was not observed in response to hypox-
ia, whereas activation of p38 could be demonstrated (26). In
terms of p38, several studies have reported its critical role under
hypoxia (26, 31), which is compatible with our data. To our
knowledge, the roles of MAP kinases in CTGF regulation of
renal tubular cells in response to hypoxia have not been pre-
viously examined. Therefore the one new finding is that hypox-
ia induces the expression of CTGF in a p38 MAPK-dependent
manner. Demonstration of different roles of MAP kinases under
hypoxic condition would be important in the investigation
of the mechanisms regulating CTGF expression.
The present work has focused on TGF-βas a mediator to
increase the expression of CTGF gene by hypoxia in cultured
renal tubular cells. Since CTGF acts as a mediator of TGF-β 1
signaling, we hypothesized that hypoxia-induced TGF-βcon-
tributes to CTGF expression. Although TGF-β 1 activity in-
creased in response to hypoxia, the addition of the neutraliz-
ing anti-TGF-β 1 antibody did not block the hypoxia-induced
CTGF expression. These data suggest that TGF-β 1 is not the
primary mediator of the hypoxia-induced CTGF expression
in renal tubular cells. Also, hypoxia-induced CTGF expres-
sion seems not to be from the increased bioactivity of TGF-β 1.Hypoxic Induction of CTGF via TGF-beta1-Independent Mechanism S181
Our data examining signaling pathways involved in CTGF
gene expression are in good agreement with some recent stud-
ies. Recent study showed that TGF-β 1 signaling was not re-
quired for hypoxic induction of CTGF promotor activity in
renal tubular cells (14). The mechanisms by which hypoxia
stimulates CTGF gene expression remain to be worked out
but appear to be independent of TGF-β 1. Limitations of our
study were that the level of CTGF protein and in particular
secreted protein were not measured, while mRNA expression
was important.
In summary, this study demonstrates that hypoxia up-reg-
ulates CTGF gene expression in cultured tubular cells and
hypoxia-induced CTGF activation is dependent on p38 MAP
kinase. Based on our study on CTGF gene regulation, we have
identified that hypoxia regulates CTGF expression through
TGF-β 1-independent pathway. The data suggest an important
role of CTGF in fibrogenic effect by hypoxia. Understand-
ing the molecular mechanisms by which hypoxia induced
fibrosis may open new avenues to the treatment of progres-
sive renal diseases.
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